An ABO Incompatible Liver Transplant (ABOi Liver Transplant) is a liver transplant procedure in which the donor and recipient have different blood groups. Traditionally, liver transplantation was performed between donors and recipients with compatible blood groups. However, advances in transplant medicine now make it possible to safely perform liver transplants even when blood groups do not match.
Before the transplant, specialized treatments are used to reduce the recipient’s antibodies that could attack the donor liver. These treatments may include plasmapheresis, immunosuppressive medications, and antibody-targeted therapies. Careful monitoring before and after surgery helps minimize the risk of rejection and ensures the best possible outcomes.
An ABO Incompatible Liver Transplant is a procedure in which a patient receives a liver from a donor with a different blood group. Specialized treatments are used to reduce the risk of rejection and ensure a successful transplant.
Yes. With modern immunosuppressive therapies, antibody reduction protocols, and careful monitoring, ABO incompatible liver transplants can achieve excellent outcomes in selected patients.
It is performed when a suitable blood-group-compatible donor is unavailable or when urgent transplantation is required and waiting for a compatible donor may not be possible.
Specialized treatments such as plasmapheresis, immunotherapy, and immunosuppressive medications are used before and after transplantation to lower antibody levels and reduce rejection risk.
Patients with end-stage liver disease, liver failure, liver cirrhosis, certain liver cancers, or urgent transplant needs may be considered after a detailed evaluation by the transplant team.